Prevalence, clinical significance, and risk factors of arrhythmic mitral valve prolapse - results of the MITPROL AR-PL Registry.

29 August 2025 (07:00 - 18:00)

Organised by:

Sign in for access options

Sign in to view the resources

Sign in for access options

About the speaker

Doctor Dominika Dziadosz

Medical University of Silesia, Katowice (Poland)

5 More presentations in this session

Presentation thumbnail

Prognostic impact of resting and exercise right ventricular to pulmonary artery coupling in patients with dynamic mitral regurgitation

Doctor J. Glasmacher (Duesseldorf, DE)

Abstract Slides Video

Presentation thumbnail

Sex-specific patterns in worldwide burden of non-rheumatic degenerative mitral valve disease between 1990 and 2021, results from the Global Burden of Disease Study 2021

Doctor J. Ma (Beijing, CN)

Abstract Slides Video

Presentation thumbnail

Comorbidities and excess mortality of patients with moderate mitral regurgitation

Doctor S. Elimeleh (Ramat Gan, IL)

Abstract Slides Video

Presentation thumbnail

The REVEAL-AFMR score: development and validation of a prognostic model for patients with atrial functional mitral regurgitation

Doctor H. Kago (Tokyo, JP)

Abstract Slides Video

Presentation thumbnail

Predictors of mitral regurgitation improvement in functional mitral regurgitation: insights from ventricular and atrial remodeling

Doctor C. Lu (Taoyuan, TW)

Abstract Slides Video

Access the full session

Session thumbnail

Mitral regurgitation and clinical consequences

The Event

Event poster

ESC Congress 2025

29 August - 1 September 2025

You may be interested in

Congress Presentation

Discussant review - SAVE-MVP

Congress Presentation

Discussion - SAVE-MVP

Congress Presentation

Mitral valve prolapse: an innocent bystander or a deadly disease?

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources